Assertio (ASRT)

• Market cap: $91.1M
• 1 day: 12.69%
• 5 days: 16.85%
• 1 month: 16.72%
• 3 months: 43%
• 6 months: 29.78%
• Year to date: 11.34%
• 1 year: -27.19%
• 5 years: -67.81%
• 10 years: -99.18%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Employees: 30

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

1,622% more call options, than puts

Call options by funds: $861K | Put options by funds: $50K

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

4% more funds holding

Funds holding: 68 [Q1] → 71 (+3) [Q2]

0.69% less ownership

Funds ownership: 26.52% [Q1] → 25.83% (-0.69%) [Q2]

6% less capital invested

Capital invested by funds: $17.1M [Q1] → $16.1M (-$1.07M) [Q2]

48% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 23

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $3
• Avg. target: $3
• High target: $3

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Raghuram Selvaraju

$3

Buy Maintained

12 Aug 2025